Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 14.504\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a Cc1ccc(CNc2cnccn2)cc1
b CCOc1cccc(CNn2cnnc2)c1OCc1ccccc1Cl
c CN1CCN(c2ccc(NC(=O)CN3CCOCC3)cc2F)CC1
d CCc1ccc(Oc2nc([N+](=O)[O-])nn2C)cc1
e CC(=O)c1ccc(-n2c(CCC(=O)O)ccc2-c2ccccc2)cc1
Answer: c. CN1CCN(c2ccc(NC(=O)CN3CCOCC3)cc2F)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN1CCN(c2ccc(NC(=O)CN3CCOCC3)cc2F)CC1
CN1CCN(c2ccc(NC(=O)CN3CCOCC3)cc2F)CC1
N-[3-fluoro-4-(4-methylpiperazin-1-yl)phenyl]-2-morpholin-4-ylacetamide